These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17200247

  • 41. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
    Belmaker I, Dukhan L, Yosef Y, Leventhal A, Dagan R.
    Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
    [Abstract] [Full Text] [Related]

  • 42. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O, El-Sayed N, Sanders JW, Abd-Rabou Z, Antil L, Bresee J, Mansour A, Adib I, Nahkla I, Riddle MS.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [Abstract] [Full Text] [Related]

  • 43. Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects.
    Claes C, Reinert RR, von der Schulenburg JM.
    Eur J Health Econ; 2009 Feb 01; 10(1):25-38. PubMed ID: 18379830
    [Abstract] [Full Text] [Related]

  • 44. Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
    Bergman A, Hjelmgren J, Ortqvist A, Wisløff T, Kristiansen IS, Högberg LD, Persson KM, Persson U.
    Scand J Infect Dis; 2008 Feb 01; 40(9):721-9. PubMed ID: 18712627
    [Abstract] [Full Text] [Related]

  • 45. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK, Botham L, Schoub BD.
    Vaccine; 2006 Jul 17; 24(29-30):5670-8. PubMed ID: 16766096
    [Abstract] [Full Text] [Related]

  • 46. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D, Kilgore PE, Clemens JD, Wei L, Zhi-Yi X.
    Bull World Health Organ; 2003 Jul 17; 81(5):334-42. PubMed ID: 12856051
    [Abstract] [Full Text] [Related]

  • 47. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E, Shattock AG, Fielding JF.
    Am J Gastroenterol; 2000 Jan 17; 95(1):223-6. PubMed ID: 10638588
    [Abstract] [Full Text] [Related]

  • 48. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model.
    Trotter CL, Edmunds WJ.
    Med Decis Making; 2006 Jan 17; 26(1):38-47. PubMed ID: 16495199
    [Abstract] [Full Text] [Related]

  • 49. Costs associated with ventricular assist device use in children.
    Mahle WT, Ianucci G, Vincent RN, Kanter KR.
    Ann Thorac Surg; 2008 Nov 17; 86(5):1592-7. PubMed ID: 19049755
    [Abstract] [Full Text] [Related]

  • 50. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA.
    Vaccine; 2004 May 07; 22(15-16):1862-7. PubMed ID: 15121296
    [Abstract] [Full Text] [Related]

  • 51. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective.
    Ho AM, Nelson EA, Walker DG.
    Arch Dis Child; 2008 Jan 07; 93(1):52-8. PubMed ID: 17855438
    [Abstract] [Full Text] [Related]

  • 52. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.
    Giorgi-Rossi P, Merito M, Borgia P.
    Health Policy; 2009 Feb 07; 89(2):225-38. PubMed ID: 18639952
    [Abstract] [Full Text] [Related]

  • 53. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB.
    Southeast Asian J Trop Med Public Health; 2004 Sep 07; 35(3):693-6. PubMed ID: 15689089
    [Abstract] [Full Text] [Related]

  • 54. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
    Siraprapasiri T, Sawaddiwudhipong W, Rojanasuphot S.
    Southeast Asian J Trop Med Public Health; 1997 Mar 07; 28(1):143-8. PubMed ID: 9322297
    [Abstract] [Full Text] [Related]

  • 55. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS, Davis MM.
    Prev Med; 2006 Mar 07; 42(3):240-6. PubMed ID: 16480761
    [Abstract] [Full Text] [Related]

  • 56. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.
    Welte R, van den Dobbelsteen G, Bos JM, de Melker H, van Alphen L, Spanjaard L, Rümke HC, Postma MJ.
    Vaccine; 2004 Dec 09; 23(4):470-9. PubMed ID: 15530695
    [Abstract] [Full Text] [Related]

  • 57. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ, Rosenthal P, Meyerhoff AS.
    Vaccine; 2004 Mar 12; 22(9-10):1241-8. PubMed ID: 15003653
    [Abstract] [Full Text] [Related]

  • 58. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
    Fisenka EG, Germanovich FA, Glinskaya IN, Lyabis OI, Rasuli AM.
    J Viral Hepat; 2008 Oct 12; 15 Suppl 2():57-61. PubMed ID: 18837836
    [Abstract] [Full Text] [Related]

  • 59. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
    Li X, Xu Z, Hofman A.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr 12; 19(2):93-6. PubMed ID: 10322718
    [Abstract] [Full Text] [Related]

  • 60. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Sur D, Anh DD, Agtini M, Bhutta Z, DOMI Typhoid Economics Study Group.
    Vaccine; 2008 Nov 25; 26(50):6305-16. PubMed ID: 18835415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.